SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CVSI

CV Sciences, Inc. (OTC:CVSI)

US · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
$0.01+$0.00 (+0.00%)
 
Market cap
$2.42M
Insider Score
Health Score
Analyst consensus
Listed since
Feb 12, 2013
Market Cap$2.42M-64.8%
Revenue (ttm)$12.52M-12.9%
Net Income-$1.72M-16.2%
EPS-$0.01-8.7%
Shares Out242.18M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume767,535
Open$0.01
Previous Close$0.01
Day's Range$0.01 - $0.01
52-Week Range$0.01 - $0.10
Beta0.43
AnalystsHold
Price Targetn/a
Earnings DateApr 1, 2027
+0.00% (1D)
No price history available.

About CVSI

CV Sciences, Inc. functions as a life sciences organization primarily operating across North America. Its business activities are organized into two distinct divisions: Consumer Products and Specialty Pharmaceutical. The Consumer Products division focuses on the creation, manufacturing, and commercialization of plant-derived dietary supplements and cannabidiol (CBD) products sourced from hemp. These offerings are marketed under various brand identities including PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense, and PlusCBD Pet. They serve a wide array of health and wellness sectors such as nutraceuticals, personal care, specialty food items, and pet products. The company distributes these goods through its own digital platforms, other online retailers, a network of chosen distributors, and traditional brick-and-mortar stores. In contrast, the Specialty Pharmaceutical division is dedicated to the research, advancement, and eventual market launch of cannabinoids for the treatment of specific medical conditions. A key project in this segment involves the drug candidate CVSI-007, an innovative combination of CBD and nicotine designed to combat smokeless tobacco use and dependence. Established in 2010, the company was initially known as CannaVest Corp. before officially adopting the name CV Sciences, Inc. in January 2016. Its main corporate offices are located in San Diego, California.

Address
9530 Padgett Street, San Diego, CA, 92126, US
Market Cap
2 million
Employees
43
Industrial Classification
Drug Manufacturers - Specialty & Generic

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$189.53K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Fair
From CVSI’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
+0.00%
5 Days
+11.11%
1 Month
+0.00%
6 Months
-67.19%
1 Year
-64.79%

$CVSI stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CVSI holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CVSI's directors and management

Net Shares Purchased by Insiders−8M−4M02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CVSI Estimated quarterly lobbying spending

Source: U.S. Senate LDA

CVSI Revenue by Segment

$3.50MTotal
Product sales, net$3.03M86.56%
Loss on debt conversions$263.00K7.52%
Change in fair value of convertible notes$207.00K5.92%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New CVSI patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CVSI from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from CVSI’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
100% of score
0
Analyst Ratings
No data yet
—
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
17
Sells
0
Buy Value
$189.53K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.